InsightsPremium
Immatics logo

Immatics

6 Followers

About

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.

Leadership Houston

Profile photo of Ali Mohamed, VP, CMC at Immatics
Ali Mohamed
VP, CMC
Profile photo of Arun Satelli, Associate Director, Discovery Group at Immatics
Arun Satelli
Associate Director, Discovery Group
Profile photo of Chih-Chiang Tsou, Principal Scientist Bioinformatics at Immatics
Chih-Chiang Tsou
Principal Scientist Bioinformatics
Profile photo of Jessica Mosby, Senior Director, Human Resources & Operations at Immatics
Jessica Mosby
Senior Director, Human Resources & Operations
Profile photo of Jorge M. Rivas, Associate Director, Regulatory Affairs at Immatics
Jorge M. Rivas
Associate Director, Regulatory Affairs
Profile photo of Kerry Sieger, Director, QA/QC at Immatics
Kerry Sieger
Director, QA/QC
Profile photo of Mamta Kalra, Director, CMC at Immatics
Mamta Kalra
Director, CMC
Profile photo of Riky Tran, Director IT, Immatics US at Immatics
Riky Tran
Director IT, Immatics US
Profile photo of Sheree Brooks, Director of Program Management at Immatics
Sheree Brooks
Director of Program Management
Profile photo of Zoe Coughlin, Director, CMC at Immatics
Zoe Coughlin
Director, CMC

Leadership Munich

Profile photo of Ajla Hrle, Director Strategic Alliances at Immatics
Ajla Hrle
Director Strategic Alliances
Profile photo of Anja Heuer, Corporate Communications Manager at Immatics
Anja Heuer
Corporate Communications Manager
Profile photo of Claudia Blattner, Director, Business Development & Partnering at Immatics
Claudia Blattner
Director, Business Development & Partnering
Profile photo of Miriam Meyer, Senior Director, EU Regulatory Affairs at Immatics
Miriam Meyer
Senior Director, EU Regulatory Affairs
Profile photo of Patricia Miranda Brucker, Director Global QM at Immatics
Patricia Miranda Brucker
Director Global QM
Profile photo of Wolfgang Flasche, Director, Intellectual Property at Immatics
Wolfgang Flasche
Director, Intellectual Property

Leadership Tübingen

Profile photo of Andrea Mayer, Senior Director Clinical Operations & Clinical Development at Immatics
Andrea Mayer
Senior Director Clinical Operations & Clinical Development
Profile photo of Carolin Mauch, Associate Director, Financial Planning & Analysis at Immatics
Carolin Mauch
Associate Director, Financial Planning & Analysis
Profile photo of Claudia Wagner, Director Immunology at Immatics
Claudia Wagner
Director Immunology
Profile photo of Daniel Lübberstedt, Global Head of IT at Immatics
Daniel Lübberstedt
Global Head of IT
Profile photo of Dominik Maurer, VP Immunology at Immatics
Dominik Maurer
VP Immunology
Profile photo of Ephraim Hofsäß, Director External Reporting at Immatics
Ephraim Hofsäß
Director External Reporting
Profile photo of Frank Schwöbel, Associate Director, Preclinical Pharmacology & Pharmacokinetics at Immatics
Frank Schwöbel
Associate Director, Preclinical Pharmacology & Pharmacokinetics
Profile photo of Heiko Schuster, Associate Director Target Discovery at Immatics
Heiko Schuster
Associate Director Target Discovery
Profile photo of Maria Poulada, Director Finance at Immatics
Maria Poulada
Director Finance
Profile photo of Martin Hofmann, Associate Director Immunology at Immatics
Martin Hofmann
Associate Director Immunology
Profile photo of Martina Ott, Associate Director Target Validation at Immatics
Martina Ott
Associate Director Target Validation
Profile photo of Norbert Hilf, VP, Translational Development at Immatics
Norbert Hilf
VP, Translational Development
Profile photo of Oliver Schoor, VP, Target Research at Immatics
Oliver Schoor
VP, Target Research
Profile photo of Regina Mendrzyk, Director Immunology at Immatics
Regina Mendrzyk
Director Immunology
Profile photo of Sabrina Kuttruff-Coqui, Senior Director Capital Markets & Business Planning at Immatics
Sabrina Kuttruff-Coqui
Senior Director Capital Markets & Business Planning
Profile photo of Sarah Missel, Senior Director Translational Development, R&D Strategy and Communications at Immatics
Sarah Missel
Senior Director Translational Development, R&D Strategy and Communications
Profile photo of Sebastian Bunk, Senior Director, Immunology at Immatics
Sebastian Bunk
Senior Director, Immunology
Profile photo of Sonja Dorner, Associate Director, CMC at Immatics
Sonja Dorner
Associate Director, CMC
Profile photo of Carsten Reinhardt, Managing Director and Chief Development Officer at Immatics
Carsten Reinhardt
Managing Director and Chief Development Officer
Profile photo of Cedrik Britten, Chief Medical Officer at Immatics
Cedrik Britten
Chief Medical Officer
Profile photo of Edward Sturchio, General Counsel at Immatics
Edward Sturchio
General Counsel
Profile photo of Jordan Silverstein, Head of Strategy at Immatics
Jordan Silverstein
Head of Strategy
Profile photo of Manuel Jans, VP People & Organization at Immatics
Manuel Jans
VP People & Organization
Profile photo of Michael Mølhøj, Senior Director CMC Biologics at Immatics
Michael Mølhøj
Senior Director CMC Biologics
Profile photo of Rainer Kramer, Managing Director and Chief Business Officer at Immatics
Rainer Kramer
Managing Director and Chief Business Officer
Profile photo of Steffen Walter, Chief Technology Officer at Immatics
Steffen Walter
Chief Technology Officer
Profile photo of Toni Weinschenk, Chief Innovation Officer at Immatics
Toni Weinschenk
Chief Innovation Officer
Profile photo of Arnd Christ, Chief Financial Officer at Immatics
Arnd Christ
Chief Financial Officer
Delfi Krishna
Senior Director Strategic Operations
Jessica Cordes
Senior Director Clinical Operations

No teams yet!

No jobs yet!

Team announcement

Immatics Biotechnologies Announces Cedrik Britten, as Chief Medical Officer

Immatics Biotechnologies Announces Cedrik Britten, as Chief Medical Officer

Clinical-stage cancer immunotherapy provider Immatics Biotechnologies GmbH has announced the appointment of Cedrik Britten, MD, as Chief Medical Officer (CMO) effective June 1, 2020. In the role, Dr. Britten will be responsible for the global clinical development of Immatics’ pharmaceutical pipeline and will report directly to company CEO Harpreet Singh. “We are excited about Cedrik joining Immatics. He has an extensive background in cell therapy, translational oncology, and immunology, as well as great experience in leading clinical and preclinical development programs in immuno-oncology. His appointment will complement Immatics’ existing strengths and capabilities as we continue the clinical development of our targeted immunotherapies with an emphasis on treating solid tumors through our two therapeutic modalities, Adoptive Cell Therapy and TCR Bispecifics,” commented Dr. Singh. Dr. Britten brings over ten years of experience with drug development to the leadership team at Immatics. He joins the team after serving as Vice President and Head of the Oncology Cell Therapy Research Unit at GlaxoSmithKline in the UK were he oversaw Oncology R&D and their cell therapy pipeline. Dr. Britten also previously served as the Vice President of R&D at German immunotherapy provider BioNTech. “Immatics is bringing together three synergizing core elements that attracted me: excellent science, powerful proprietary technology platforms for the discovery of relevant targets, and T cell receptors tailored for use across a range of therapeutic modalities and a vibrant corporate culture focused on serving patients in need. These three cornerstones have enabled Immatics to reach a dynamic stage of growth with four ongoing clinical trials and a promising pipeline of several product candidates in development,” said Cedrik Britten.

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.